The COVID-19 Pandemic – Products
Product News
Jean-Marc Huët To Succeed Albert M. Baehny as Chairman of Lonza
Longstanding Chairman of Lonza, Albert Baehny will not stand for re-election. Jean-Marc Huët, currently Chairman of Heineken N.V. with strong international leadership track record to be proposed as the new Chairman of Lonza at the 2024 AGM.
Whitepaper
Heralding a New Era of RNA Therapeutics
This article explores how scientists are tackling the challenges and intensifying efforts to develop mRNA therapeutics for different diseases.
Product News
Thermo Fisher Scientific Introduces New Sample Preparation Solutions To Simplify and Automate Respiratory Diagnostic Testing
New Thermo Scientific KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit improve preanalytical workflows for clinical laboratories.
Compendium
Revolutionizing Pharmaceutical Quality Control: A Roadmap to Innovation and Efficiency
In this compendium Technology Networks presents a collection of handpicked informative resources including articles, industry insights, a listicle and whitepaper that cover some of the latest challenges and opportunities in the quality control space.
Product
Advertisement
Applied Biosystems TaqPath COVID-19, Flu A/B, RSV Combo Kit: Multiplex PCR Test
Because RSV, influenza, and COVID-19 share symptoms, accurate testing is needed to distinguish one from the other. The CE-IVD marked multiplex TaqPath COVID-19, Flu A/B, RSV Combo Kit is specifically designed to detect and differentiate between these three viruses during flu season
Product News
Biovectra Signs Service Agreement With Acuitas Therapeutics for Unique Lipid Nanoparticle (Lnp) Delivery System Used in Manufacturing mRNA-Based Therapies
Partnership between two Canadian life sciences leaders offers a commercial GMP manufacturing solution for Acuitas’ licensed partners developing promising next generation therapies.
Compendium
mRNA Ready To Make Its Mark: Developing the mRNA Therapeutics of the Future
It was the mRNA vaccine that led the charge against SARS-CoV-2 in the recent pandemic, but now researchers are asking: what other therapeutic applications could benefit from mRNA technology?
Product News
NIH and Exothera Collaborate To Produce GMP Intranasal Vaccine Against SARS-CoV-2
The National Institutes of Health selected Exothera S.A. therapeutics to develop the manufacturing process for NIH’s intranasal vaccine against SARS-CoV-2.
Whitepaper
The Future of Diagnostics
While the industry was put front and center during the COVID-19 pandemic, diagnostics have always been critical in treating illnesses and managing health. Technological advances, innovative platforms, and decentralized test options are driving exciting developments and optimism across the diagnostics industry.
Product News
Nanopore Technology Achieves Breakthrough in Protein Variant Detection
A team of scientists led by the University of Oxford have achieved a significant breakthrough in detecting modifications on protein structures.
Advertisement
